![William_sjostrom_2]( "William_sjostrom_2")
One of the the year’s biggest busted deals is likely to result in a blizzard of litigation, and a key issue will be a nice question of contract interpretation: Did a recall of some medical devices and accompanying regulatory investigations constitute a “material adverse effect” on Guidant Corp. that would let Johnson & Johnson back way from its planned $25.4 billion takeover? Guidant says no, and plans to sue.
Our colleague Bill Sjostrom (left) of Northern Kentucky has some interesting posts on the case over at BusinessLaw Prof:
J&J/Guidant Deal Update
J&J/Guidant Deal in Jeopardy
Spitzer Sues Guidant
USA Today Article On J&J/Guidant Deal
[Frank Snyder]
